Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492817 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Single Session Stereotactic Body Radiotherapy
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 71
- Enrollment target
NCT00492817: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00492817 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00492817, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 71 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if stereotactic body radiotherapy to the spine using computerized tomography (CT)-on-Rails is safe and effective in the treatment of metastatic spine tumors. Objectives: * Establish the safety and efficacy of using stereotactic body radiotherapy (SBRT) to treat spine and para-spinal tumors in a single session. * Document frequency and severity of pain, symptoms and symptom interference, as well as quality of life before and after treatment. * Document changes in neurological function at defined intervals compared to pre-treatment neurological function.
Interventions
- PROCEDURE Stereotactic Body Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2005-10-13 |
| Est. Completion | 2024-11-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00492817
The ClinicalTrials.gov registry entry for NCT00492817 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiotherapy is the first listed.
NCT00492817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00492817 about?
NCT00492817 is a clinical study titled "Evaluation of Single Session Stereotactic Body Radiotherapy". The goal of this clinical research study is to find out if stereotactic body radiotherapy to the spine using computerized tomography (CT)-on-Rails is safe and effective in the treatment of metastatic spine tumors. Objectives: * Establish the safety and efficacy of using stereotactic body radiother...
What is the current status of trial NCT00492817?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 71 participants. The study started on 2005-10-13. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT00492817?
The interventions under investigation include: Stereotactic Body Radiotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT00492817?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.